A review of the close surveillance policy for stage I female germ cell tumors of the ovary and other sites

International Journal of Gynecological Cancer

Volumn 18, Issue 1, 2008, Pages 43-50

  Patterson, D M ^a   Murugaesu, N ^b   Holden, L ^b   Seckl, M J ^b   Rustin, G J S ^a  

^a MOUNT VERNON HOSPITAL   (United Kingdom)

^b CHARING CROSS HOSPITAL   (United Kingdom)

Author keywords

Chemotherapy; Dysgerminoma; Nondysgerminoma; Ovarian germ cell tumor; Stage I; Surveillance

Indexed keywords

BLEOMYCIN; CISPLATIN; CYCLOPHOSPHAMIDE; DACTINOMYCIN; ETOPOSIDE; METHOTREXATE; PLATINUM DERIVATIVE; TUMOR MARKER; VINCRISTINE;

ADOLESCENT; ADULT; ARTICLE; CANCER CHEMOTHERAPY; CANCER MORTALITY; CANCER RELAPSE; CANCER STAGING; CANCER SURVIVAL; CLINICAL ARTICLE; DYSGERMINOMA; FEMALE; GERM CELL TUMOR; HUMAN; OVARY TUMOR; PRIORITY JOURNAL; TERATOMA;

ADOLESCENT; ADULT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; DYSGERMINOMA; FEMALE; HUMANS; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; OVARIAN NEOPLASMS; POPULATION SURVEILLANCE; PROGNOSIS; RISK MANAGEMENT; TERATOMA; TREATMENT OUTCOME; TUMOR MARKERS, BIOLOGICAL;

EID: 38049087691     PISSN: 1048891X     EISSN: 15251438     Source Type: Journal    
DOI: 10.1111/j.1525-1438.2007.00969.x     Document Type: Article

References (32)

1. Quirk JT, Natarajan N. Ovarian cancer incidence in the United States, 1992-1999. Gynecol Oncol 2005 97 : 519 23.
2. Thomas GM, Dembo AJ, Hacker NF, DePetrillo AD. Current therapy for dysgerminoma of the ovary. Obstet Gynecol 1987 70 : 268 75.
3. Williams S, Blessing JA, Liao SY et al. Adjuvant therapy of ovarian germ cell tumors with cisplatin, etoposide, and bleomycin: a trial of the Gynecologic Oncology Group. J Clin Oncol 1994 12 : 701 6.
4. Segelov E, Campbell J, Ng M et al. Cisplatin-based chemotherapy for ovarian germ cell malignancies: the Australian experience. J Clin Oncol 1994 12 : 378 84.
5. Gershenson DM. Management of early ovarian cancer: germ cell and sex cord-stromal tumors. Gynecol Oncol 1994 55 : S62 72.
6. Dark GG, Bower M, Newlands ES. Surveillance policy for stage I ovarian germ cell tumours. J Clin Oncol 1997 15 : 620 4.
7. FIGO Cancer Committee. Staging announcement. Gynecol Oncol 1986 25 : 383 5.
8. Murugaesu N, Schmid P, Dancey G et al. Malignant ovarian germ cell tumors: identification of novel prognostic markers and long-term outcome after multimodality treatment. J Clin Oncol 2006 24 : 4862 6.
9. Bower M, Fife K, Holden L. Chemotherapy for ovarian germ cell tumours. Eur J Cancer 1996 32A : 593 7.
10. International Germ Cell Cancer Collaborative Group. International Germ Cell Consensus Classification: a prognostic factor-based staging system for metastatic germ cell cancers. J Clin Oncol 1997 15 : 594 603.
11. Zanagnolo V, Sartori E, Galleri G et al. Clinical review of 55 cases of malignant ovarian germ cell tumors. Eur J Gynaecol Oncol 2004 25 : 315 20.
12. Mayordomo JI, Paz-Ares L, Rivera F et al. Ovarian and extragonadal malignant germ-cell tumors in females: a single-institution experience with 43 patients. Ann Oncol 1994 5 : 25 31.
13. Zanetta G, Bonazzi C, Cantu M et al. Survival and reproductive function after treatment of malignant germ cell ovarian tumors. J Clin Oncol 2001 19 : 1015 20.
14. Marina NM, Cushing B, Giller R et al. Complete surgical excision is effective treatment for children with immature teratomas with or without malignant elements: a Pediatric Oncology Group/Children's Cancer Group Intergroup Study. J Clin Oncol 1999 17 : 2137 43.
15. Warde P, Specht L, Horwich A et al. Prognostic factors for relapse in stage I seminoma managed by surveillance: a pooled analysis. J Clin Oncol 2002 20 : 4448 52.
16. Read G, Stenning SP, Cullen MH et al. Medical Research Council prospective study of surveillance for stage I testicular teratoma. Medical Research Council Testicular Tumors Working Party. J Clin Oncol 1992 10 : 1762 8.
17. Francis R, Bower M, Brunstrom G et al. Surveillance for stage I testicular germ cell tumours: results and cost benefit analysis of management options. Eur J Cancer 2000 36 : 1925 32.
18. Klepp O, Olsson AM, Henrikson H et al. Prognostic factors in clinical stage I nonseminomatous germ cell tumors of the testis: multivariate analysis of a prospective multicenter study. Swedish-Norwegian Testicular Cancer Group. J Clin Oncol 1990 8 : 509 18.
19. O'Connor DM, Norris HJ. The influence of grade on the outcome of stage I ovarian immature (malignant) teratomas and the reproducibility of grading. Int J Gynecol Pathol 1994 13 : 283 9.
20. Schwartz PE. Surgery of germ cell tumours of the ovary. Forum (Genova) 2000 10 : 355 65.
21. Dadmanesh F, Miller DM, Swenerton KD, Clement PB. Gliomatosis peritonei with malignant transformation. Mod Pathol 1997 10 : 597 601.
22. Norris HJ, Zirkin HJ, Benson WL. Immature (malignant) teratoma of the ovary: a clinical and pathologic study of 58 cases. Cancer 1976 37 : 2359 72.
23. Boshoff C, Begent RH, Oliver RT et al. Secondary tumours following etoposide containing therapy for germ cell cancer. Ann Oncol 1995 6 : 35 40.
24. Huddart RA, Norman A, Shahidi M et al. Cardiovascular disease as a long-term complication of treatment for testicular cancer. J Clin Oncol 2003 15 : 1513 23.
25. Bokemeyer C, Berger CC, Kuczyk MA, Schmoll HJ. Evaluation of long-term toxicity after chemotherapy for testicular cancer. J Clin Oncol 1996 14 : 2923 32.
26. Fossa SD. Long-term sequelae after cancer therapy - survivorship after treatment for testicular cancer. Acta Oncol 2004 43 : 134 41.
27. Oliver RT, Mason MD, Mead GM et al. Radiotherapy versus single-dose carboplatin in adjuvant treatment of stage I seminoma: a randomised trial. Lancet 2005 366 : 293 300.
28. Ezzat A, Raja M, Bakri Y. Malignant ovarian germ cell tumours - a survival and prognostic analysis. Acta Oncol 1999 38 : 455 60.
29. Perrin LC, Low J, Nicklin JL et al. Fertility and ovarian function after conservative surgery for germ cell tumours of the ovary. Aust N Z J Obstet Gynaecol 1999 39 : 243 5.
30. Gaffan J, Holden L, Newlands ES et al. Infertility rates following POMB/ACE chemotherapy for male and female germ cell tumours - a retrospective long-term follow-up study. Br J Cancer 2003 89 : 1849 54.
31. Gershenson DM, Morris M, Cangir A et al. Treatment of malignant germ cell tumors of the ovary with bleomycin, etoposide, and cisplatin. J Clin Oncol 1990 8 : 715 20.
32. Smales E, Peckham MJ. Chemotherapy of germ-cell ovarian tumours: first-line treatment with etoposide, bleomycin and cisplatin or carboplatin. Eur J Cancer 1987 23 : 469 74.